Biggest study yet backs Glaxo cervical cancer shot

GlaxoSmithKline Plc's experimental vaccine Cervarix has proved more than 90 percent effective in preventing precancerous lesions due to two types of a virus responsible for most cases of cervical cancer.

External Link: http://www.reuters.com/article/healthNews/idUSL2687568520070...